Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. - Archive ouverte HAL Access content directly
Journal Articles Blood Year : 2012

Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.

(1, 2) , (1, 3) , (4) , (2, 1) , (1, 5) , (6) , (7) , (8, 9) , (10) , (11) , (12) , (13) , (1, 2)
1
2
3
4
5
6
7
8
9
10
11
12
13
Elizabeth Macintyre

Abstract

The pathogenesis of hepatosplenic T-cell lymphoma (HSTL), a rare entity mostly derived from γδ T cells and usually with a fatal outcome, remains largely unknown. In this study, HSTL samples (7γδ and 2αβ) and the DERL2 HSTL cell line were subjected to combined gene-expression profiling and array-based comparative genomic hybridization. Compared with other T-cell lymphomas, HSTL had a distinct molecular signature irrespective of TCR cell lineage. Compared with peripheral T-cell lymphoma, not otherwise specified and normal γδ T cells, HSTL overexpressed genes encoding NK-cell-associated molecules, oncogenes (FOS and VAV3), the sphingosine-1-phosphatase receptor 5 involved in cell trafficking, and the tyrosine kinase SYK, whereas the tumor-suppressor gene AIM1 (absent in melanoma 1) was among the most down-expressed. We found highly methylated CpG islands of AIM1 in DERL2 cells, and decitabine treatment induced a significant increase in AIM1 transcripts. Syk was present in HSTL cells and DERL2 cells contained phosphorylated Syk and were sensitive to a Syk inhibitor in vitro. Genomic profiles confirmed recurrent isochromosome 7q (n = 6/9) without alterations at the SYK and AIM1 loci. Our results identify a distinct molecular signature for HSTL and highlight oncogenic pathways that offer rationale for exploring new therapeutic options such as Syk inhibitors and demethylating agents.
Fichier principal
Vignette du fichier
HSTLsubmit.bloodjournalRevision.pdf (1 Mo) Télécharger le fichier
Vignette du fichier
inserm-00730464_edited.pdf (903.63 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00730464 , version 1 (01-10-2012)

Identifiers

Cite

Marion Travert, Yenlin Huang, Laurence de Leval, Nadine Martin-Garcia, Marie-Helene Delfau-Larue, et al.. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.: Molecular Signature of Hepatosplenic T-cell Lymphoma. Blood, 2012, 119 (24), pp.5795-806. ⟨10.1182/blood-2011-12-396150⟩. ⟨inserm-00730464⟩
275 View
863 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More